Science & Innovation — Unit 25, Upper-intermediate English
B2 topical supplement — research methods, R&D, trials, and innovation vocabulary (no overlap with A2–B1 environment/science basics).
Reading: R&D Briefing — Innovation Pipeline
**Internal R&D Brief · Q2 Innovation Pipeline**
Our **innovation pipeline** currently holds three assets at different maturity stages. The clearest **breakthrough** this quarter came from materials science: **lab results** show a **renewable** polymer that meets **sustainable** sourcing criteria. The **hypothesis** — that surface tension can be reduced without solvents — now has **empirical evidence** from two independent benches. Regulatory affairs has reviewed the wording for external slides.
Engineering delivered a working **prototype** last month. **Proof of concept** is complete; the device is **patent pending** in Europe and North America. Before we **scale up**, a twelve-week **pilot project** will run in partner clinics across two regions. **R&D** spend depends on **grant funding** renewal, though finance expects approval by July. Procurement is sourcing **cutting-edge** consumables under a fixed cap.
The **clinical trial** enters phase two in August. An **interdisciplinary** team — chemists, clinicians, and data analysts — will **replicate results** from the first cohort and publish interim tables monthly. All imaging is **state-of-the-art**; analysis remains **data-driven** throughout, with independent statisticians reviewing outliers.
A parallel **field study** in coastal sites will compare sensor readings with **lab results**. If outcomes align, we will **publish findings** in a **peer-reviewed** journal before we **commercialize** with OEM partners. Until then, treat external slides as confidential. Supply chain must confirm **renewable** inputs at each **pilot project** site.
**Action:** Steering group meets 18 June · submit grant appendix by 30 June · ethics pack for phase two due 5 July
**Section 4 · Caveats attached to the polymer result**
The **breakthrough** described above is genuine and it is also considerably narrower than the summary line suggests. Colleagues quoting this brief externally should quote this section with it.
**The two benches are not independent in the sense the phrase implies.** Both used feedstock from the same supplier batch and the same reference instrument, calibrated by the same technician. They are independent teams; they are not independent conditions. A third replication using a different feedstock source is scheduled for July, and until it completes we should describe the result as reproduced rather than as independently confirmed.
**The solvent-free claim holds at laboratory temperature only.** Above 40°C the surface effect degrades sharply, and our target application in coastal deployment routinely exceeds that. This is not fatal — a formulation change may address it — but the **field study** was designed before this was known and its site selection does not test the temperature range that matters.
**"Meets sustainable sourcing criteria" refers to our internal standard**, which is stricter than one recognised external scheme and weaker than two others. Marketing has twice rendered this as "certified sustainable". It is not certified by anybody, and the claim should not appear in that form in any external material.
**What we can say with confidence.** The **hypothesis** has survived a serious attempt to falsify it. Effect sizes are large enough that measurement error is not a plausible explanation. The mechanism is understood rather than merely observed, which is what makes us willing to invest in the July replication.
**What we cannot yet say** is that it works outside the laboratory, which is the only question the board is actually asking.
The brief should have led with that distinction and did not.
Vocabulary from this unit
| Term | Meaning | Example |
|---|---|---|
| hypothesis / lab results | prediction / outcomes | Lab results support the hypothesis. |
| field study / replicate results | real-world test / confirm | Replicate results after the field study. |
| clinical trial / prototype | human test / early model | Prototype ready before the clinical trial. |
| peer-reviewed / publish findings | expert-reviewed / release | Publish findings in a peer-reviewed journal. |
| empirical evidence | observed data | Empirical evidence beats speculation. |
| Phrase | Meaning | Example |
|---|---|---|
| R&D / grant funding | research spend / awarded money | Grant funding covers R&D. |
| proof of concept / pilot project | idea works / small test | Pilot project after proof of concept. |
| innovation pipeline / scale up | ideas queue / expand | Scale up from the innovation pipeline. |
| patent pending / commercialize | application filed / sell | Commercialize once patent pending clears. |
| breakthrough / cutting-edge | major advance / latest methods | Cutting-edge tools enabled a breakthrough. |
This is the free sample from this unit. The full unit adds 1 more reading passage, comprehension questions with an answer key, the listening exercises, flashcards for the vocabulary above, and a speaking task — with your progress tracked so the next unit unlocks when you are ready for it.
Common questions
What level is this unit?
Upper-intermediate — roughly CEFR B2. If you are not sure of your level, the course places you with a short diagnostic before you start rather than making you guess.
Do I need to pay to use this?
The reading passage and vocabulary on this page are free to read. The rest of the unit — the remaining passages, the exercises, the listening, the answer key and the progress tracking — is part of the paid General English course.
Is this British or American English?
British English spelling and vocabulary, which is what most learners in Azerbaijan are taught and what IELTS expects, though both are accepted in the exam.